Foghorn Therapeutics Inc. at Guggenheim Healthcare Talks: Targeted Protein Degradation Day (Virtual) Transcript
Welcome. Thanks for joining us. My name is Michael Schmidt. I'm one of the biotech analysts at Guggenheim Securities, and it is my great pleasure to welcome Foghorn Therapeutics for this next session at this year's Targeted Protein Degradation Day here at Guggenheim.
With us today, we have Steve Bellon, Chief Scientific Officer. Steve, welcome, and thanks for joining us.
Thank you.
Questions & Answers
All right. So, I think we'll start with a brief overview and then go straight into Q&A. If there are any questions that investors want me to ask on their behalf, please just feel free to send me an email. Steve, go ahead.
Thanks very much, Michael. Really appreciate the opportunity to talk about Foghorn now, much
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
